KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Free Cash Flow (2016 - 2025)

LifeMD's Free Cash Flow history spans 14 years, with the latest figure at -$2.9 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 33.8% year-over-year to -$2.9 million; the TTM value through Dec 2025 reached $201636.0, down 98.13%, while the annual FY2025 figure was $201636.0, 98.13% down from the prior year.
  • Free Cash Flow reached -$2.9 million in Q4 2025 per LFMD's latest filing, up from -$2.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $9.9 million in Q3 2024 to a low of -$12.5 million in Q2 2022.
  • Average Free Cash Flow over 5 years is -$2.2 million, with a median of -$2.9 million recorded in 2025.
  • Peak YoY movement for Free Cash Flow: crashed 1644.08% in 2021, then soared 1363.81% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$5.8 million in 2021, then soared by 176.45% to $4.4 million in 2022, then dropped by 18.17% to $3.6 million in 2023, then crashed by 222.01% to -$4.4 million in 2024, then soared by 33.8% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Free Cash Flow are -$2.9 million (Q4 2025), -$2.9 million (Q3 2025), and $3.1 million (Q2 2025).